Literature DB >> 7207817

Cervical myelography with iopamidolo.

G Belloni, G Bonaldi, L Moschini, N Quilici.   

Abstract

A new non-ionic water-soluble contrast medium was used for cervical myelography in 65 patients. The contrast medium was injected suboccipitally or by the latent C1-C2 approach. The films were of equally good quality as those obtained with other contrast media and tolerance has been superior. The contrast medium is Iopamidolo and is available in ampoules which is further positive quality.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7207817     DOI： 10.1007/bf00342988

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  9 in total

1.  Thoracic and cervical myelography with metrizamide. Clinical experiences with a water-soluble, non-ionic contrast medium.

Authors:  I O Skalpe; P Amundsen
Journal:  Radiology       Date:  1975-07       Impact factor: 11.105

2.  Metrizamide as contrast medium for myelography and ventriculography. Preliminary clinical experiences.

Authors:  R E Gonsette
Journal:  Acta Radiol Suppl       Date:  1973

3.  Advantages of a new non ionic contrast medium. The results of animal experiments.

Authors:  A Belán; K Benda; J Fabián; J Bláha
Journal:  Ann Radiol (Paris)       Date:  1978 May-Jun

4.  [Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].

Authors:  F Smaltino; R Ciccarelli; S Cirillo; T D'Auria; A Gambardella; G La Tessa; S Meoli; A Rotondo; S Santoro
Journal:  Radiol Med       Date:  1980-04       Impact factor: 3.469

5.  Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.

Authors:  B Hammer; W Lackner
Journal:  Neuroradiology       Date:  1980-04       Impact factor: 2.804

6.  Serious neurological complications of metrizamide myelography. Report of eight cases.

Authors:  L Picard; H Vespignani; P Vieux-Rochat; C Moret; G L'espérance; J Montaut; M Wéber; J Roland
Journal:  J Neuroradiol       Date:  1979       Impact factor: 3.447

7.  Radiopaque contrast media. XLIV - Preclinical studies with a new nonionic contrast agent.

Authors:  E Felder; D Pitrè; P Tirone
Journal:  Farmaco Sci       Date:  1977-11

8.  Adverse side effects of metrizamide in myelography.

Authors:  H J Gelmers
Journal:  Neuroradiology       Date:  1979-09-26       Impact factor: 2.804

9.  Mental disorders after myelography with metrizamide and other water-soluble contrast media.

Authors:  R C Schmidt
Journal:  Neuroradiology       Date:  1980-04       Impact factor: 2.804
  9 in total
  7 in total

1.  Adverse side effects of metrizamide and iopamidolo in myelography.

Authors:  A Carella; F Federico; F Di Cuonzo; E Vinjau; P Lamberti
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

2.  Psychopathometric demonstration and quantification of mental disturbances following myelography with metrizamide and iopamidol.

Authors:  G Galle; W Huk; K Arnold
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

3.  Cervical myelography with iohexol.

Authors:  P Nakstad; O Aaserud; A Helgetveit; R Nyberg-Hansen; T Ganes; T Bach-Gansmo
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

4.  Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.

Authors:  P Bassi; A Cecchini; P Dettori; E Signorini
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

5.  Iopamidol vs metrizamide: a double blind study for cervical myelography.

Authors:  B P Drayer; M A Warner; A Sudilovsky; J Luther; R Wilkins; S Allen; M Bates
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

6.  Iohexol compared to metrizamide in cervical and thoracic myelography. A randomized double blind parallel study.

Authors:  P Nakstad; A Helgetveit; O Aaserud; T Ganes; R Nyberg-Hansen
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

7.  Sex and age related differences in postmyelographic adverse reactions. A prospective study of 1765 myelographies.

Authors:  P Maly
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.